Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Malignant Lymphoma

Free Subscription 24.11.2025 3 Am J Clin Pathol 1 Blood 1 BMC Cancer 3 Bone Marrow Transplant 2 Br J Dermatol 4 Br J Haematol 1 Int J Cancer 2 J Clin Oncol 2 Leuk Lymphoma 1 Leukemia 1 Mod Pathol 1 Oncology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Clin Pathol

1. HAMNVAG HM, Van Norman S, Chen Y, Pettit KM, et al
   Secondary review of extramural hematopathology cases for patients referred to an academic center: The increasing importance of subspecialized hematopathology practice.
   Am J Clin Pathol. 2025;164:800-805.
   PubMed         Abstract available
   
   
2. FOUCAR K, Bagg A, Arber DA, Bueso-Ramos CE, et al
   Guide to the diagnosis of lymphoid neoplasms in blood and bone marrow: A Bone Marrow Pathology Group approach.
   Am J Clin Pathol. 2025;164:650-693.
   PubMed         Abstract available
   
   
3. ZHANG Y, Qin D, Ozoya O, Glass F, et al
   Expanded CD4+CD57+ T-large granular lymphocytes: A diagnostic pitfall in blood staging of mycosis fungoides/Sezary syndrome.
   Am J Clin Pathol. 2025;164:644-649.
   PubMed         Abstract available
   
   

   
   Blood

4. TAYLOR J
   Big cells, bigger BTK resistance in mantle cell lymphoma.
   Blood. 2025;146:2500-2501.
   PubMed        
   
   

   
   BMC Cancer

5. SONG Y, Zhang Y, Zhang L, Che Y, et al
   Diagnostic value of high-frame-rate contrast-enhanced ultrasound and nomogram model in lymphomas.
   BMC Cancer. 2025;25:1789.
   PubMed         Abstract available
   
   

   
   Bone Marrow Transplant

6. CORONA M, Brown S, Rejeski K, Flynn JR, et al
   Late hematologic toxicity after CAR T-cell therapy in large B-cell lymphoma: incidence, risk factors, and clinical impact.
   Bone Marrow Transplant. 2025 Nov 18. doi: 10.1038/s41409-025-02745.
   PubMed         Abstract available
   
   
7. LINDAUER M, Reissfelder F, Hegenbart U, Luft T, et al
   Long-term disease control of monomorphic epitheliotrophic intestinal T-cell lymphoma (MEITL) with CNS involvement in a caucasian patient by allogeneic hematopoietic cell transplantation.
   Bone Marrow Transplant. 2025 Nov 15. doi: 10.1038/s41409-025-02747.
   PubMed        
   
   
8. KURIYAMA K, Watanabe M, Okatani T, Ota S, et al
   Outcomes of hematopoietic stem cell transplantation for patients with monomorphic epitheliotropic intestinal T-cell lymphoma: retrospective study from the Adult Lymphoma Working Group of the Japan Society for Transplantation and Cellular Therapy.
   Bone Marrow Transplant. 2025 Nov 15. doi: 10.1038/s41409-025-02752.
   PubMed        
   
   

   
   Br J Dermatol

9. CHEN J, Francis P, Martinez A, Marre E, et al
   Exploring sexual health in patients with cutaneous T-cell lymphoma: a mixed methods study.
   Br J Dermatol. 2025 Nov 20:ljaf466. doi: 10.1093.
   PubMed        
   
   
10. WILLEMZE R, Assaf C, Bagot M, Beylot-Barry M, et al
    EORTC/USCLC/ISCL consensus recommendations for management and treatment of cutaneous lymphoproliferative disorders.
    Br J Dermatol. 2025 Aug 6:ljaf312. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Br J Haematol

11. JUNG JM, Choi ME, Moon IJ, Won CH, et al
    Systemic immune-inflammation index and pan-immune value as prognostic indicators of clinical outcomes in mycosis fungoides: A retrospective cohort study.
    Br J Haematol. 2025;207:1902-1911.
    PubMed         Abstract available
    
    
12. HESS G, Eyre TA, Jen MH, Zhang J, et al
    A matching-adjusted indirect comparison of survival outcomes with pirtobrutinib (BRUIN) versus standard of care (SCHOLAR-2) in relapsed/refractory mantle cell lymphoma previously treated with a covalent Bruton tyrosine kinase inhibitor.
    Br J Haematol. 2025 Nov 17. doi: 10.1111/bjh.70237.
    PubMed        
    
    
13. THIRUVENGADAM SK, Popplewell LL, Herrera AF, Mei M, et al
    Mosunetuzumab is effective and well tolerated in older patients with relapsed/refractory follicular lymphoma: Subgroup analysis of a phase I/II study.
    Br J Haematol. 2025 Nov 18. doi: 10.1111/bjh.70212.
    PubMed         Abstract available
    
    
14. DONATI G, Nicoli P, Miele F, Podini P, et al
    Combinatorial targeting of MYC/BCL2-associated vulnerabilities in high-grade B-cell lymphoma.
    Br J Haematol. 2025 Nov 18. doi: 10.1111/bjh.70249.
    PubMed        
    
    

    
    Int J Cancer

15. WANG X, Yang W, Xing H, Wang X, et al
    The efficacy and survival impact of chidamide on angioimmunoblastic T-cell lymphoma based on Epstein-Barr virus stratification in the real world: A multicenter study.
    Int J Cancer. 2025 Nov 20. doi: 10.1002/ijc.70251.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

16. MORSCHHAUSER F, Salles G, Sehn LH, Herrera AF, et al
    Erratum: Five-Year Outcomes of the POLARIX Study Comparing Pola-R-CHP and R-CHOP in Patients With Diffuse Large B-Cell Lymphoma.
    J Clin Oncol. 2025 Nov 20:JCO2502667. doi: 10.1200/JCO-25-02667.
    PubMed        
    
    
17. MAZIARZ RT, Bishop MR, Tam CS, Borchmann P, et al
    Five-Year Analysis of the JULIET Trial of Tisagenlecleucel in Patients With Relapsed/Refractory Large B-Cell Lymphoma.
    J Clin Oncol. 2025 Nov 18:JCO2500507. doi: 10.1200/JCO-25-00507.
    PubMed         Abstract available
    
    

    
    Leuk Lymphoma

18. SUN Y, Aviv H
    Neuroendocrine transdifferentiation of aggressive B-cell leukemia/lymphoma post CAR-T therapy.
    Leuk Lymphoma. 2025 Nov 19:1-4. doi: 10.1080/10428194.2025.2589375.
    PubMed        
    
    
19. DENG C, Agarwal N, Sindel AD
    Emerging first-line treatment approaches for mantle cell lymphoma.
    Leuk Lymphoma. 2025 Nov 17:1-11. doi: 10.1080/10428194.2025.2586079.
    PubMed         Abstract available
    
    

    
    Leukemia

20. VALLOIS D, Missiaglia E, Veloza L, Fischer A, et al
    Correction: Divergent molecular pathways drive monomorphic epitheliotropic and enteropathy-associated intestinal T-cell lymphoma.
    Leukemia. 2025 Nov 20. doi: 10.1038/s41375-025-02808.
    PubMed        
    
    

    
    Mod Pathol

21. BURRONI B, Lamaison C, Poullot E, Pirlog R, et al
    Follicular Helper T-Cell Lymphomas With Epstein-Barr Virus-Positive Neoplastic Cells: A Rare Scenario With Diagnostic Implications.
    Mod Pathol. 2025;38:100875.
    PubMed         Abstract available
    
    

    
    Oncology

22. WANG Z, Wei C, Shen KN, Cai H, et al
    Real-World Comparative Analysis of Polatuzumab Vedotin-Based Pola-R-CHP Versus Standard R-CHOP in Diffuse Large B-Cell Lymphoma: A Propensity Score-Matched Cohort Study.
    Oncology. 2025 Nov 20:1-21. doi: 10.1159/000549477.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.